Table 1.
Clinical characteristics of study population (n = 80), risk factors and comorbidities.
| Gender (Male) | 34 | 42% |
| Age (years) | 81 | 76.7–84.0 |
| Weight (Kg) | 73 | 69.8–75.3 |
| Height (cm) | 164 | 164.2–167.9 |
| BMI (kg/m2) | 26 | 25.5–27.1 |
| BSA (m2) | 1.8 | 1.78–1.86 |
| SAP (mmHg) | 137.6 | 133–141 |
| DAP (mmHg) | 71.5 | 68–74 |
| Smokers | 11 | 13.6% |
| Family history of cerebro-vascular disease | 18 | 22.2% |
| Diabetes Mellitus | 21 | 25.9% |
| Hypertension | 70 | 86.4% |
| Dyslipidaemia | 11 | 13.6% |
| Obesity | 16 | 19.7% |
| History of Angina | 24 | 29.6% |
| CAD (<50% Epicardial Vessels) | 35 | 43.2% |
| COPD | 18 | 22.2% |
| NYHA class I/II | 48 | 59.3% |
| NYHA class >II | 33 | 40.7% |
| Syncope | 9 | 11.1% |
| Atrial Fibrillation | 9 | 11.1% |
| eGFR (mL/min/1.73 m2) | 58.667 | 46.4–76.1 |
| CKD | 46 | 56.8% |
| Anaemia | 18 | 22.2% |
| White Blood Cells (103/µL) | 8 | 5–10.5 |
| Erythrocytes (106/µL) | 4 | 3.5–6 |
| Platelets (103/µL) | 180 | 140–230 |
| EuroSCORE II (%) | 2.6 | 1.7–4.0 |
| Logistic EuroSCORE (%) | 8.38 | 4.7–15.1 |
Note: the data are presented as number and %, mean and 95% confidence intervals if normally distributed or median and range interquartile if not normally distributed.
BMI: body mass index; BSA: body surface area; CAD: coronary artery disease; CKD: chronic kidney disease; COPD: chronic obstructive pulmonary disease; DAP: diastolic arterial pressure; eGFR: estimated glomerular filtration rate; NYHA: New York Heart Association; SAP: systolic arterial pressure.